Antineoplastic and apoptotic effects of cannabinoids. N-acylethanolamines: protectors or killers?

V M Pushkarev1, O I Kovzun, M D Tronko

  • 1Institute of Endocrinology and Metabolism, AMS of Ukraine, Kyiv, Ukraine. endo@i.kiev.ua

Experimental Oncology
|April 29, 2008
PubMed

Insights

Cannabinoids, including N-acylethanolamines, show promise as anticancer agents by inducing tumor cell death. Research suggests these compounds may actively cause damage under stress, rather than just being a result of it.

Area of Science:

  • Pharmacology
  • Oncology
  • Cell Biology

Background:

  • Cannabinoids possess known proapoptotic and antineoplastic properties.
  • N-acylethanolamines are a class of cannabinoids with significant biological activity.
  • Tumor cell apoptosis and necrosis are key targets in cancer therapy.

Purpose of the Study:

  • To analyze the proapoptotic and antineoplastic effects of cannabinoids, focusing on N-acylethanolamines.
  • To explore the receptors and signaling pathways involved in cannabinoid-mediated apoptosis.
  • To evaluate conflicting evidence regarding the dual pro- and anti-apoptotic roles of cannabinoids.

Main Methods:

  • Literature review and analysis of existing research on cannabinoid effects.
  • Examination of studies investigating cannabinoid interactions with cellular targets.
  • Evaluation of evidence for both cell-damaging and cell-protective effects.

Main Results:

  • Cannabinoids demonstrably enhance apoptotic and necrotic processes in various tumor cells and tissues.
  • Multiple receptor types and signaling pathways mediate these proapoptotic effects.
  • N-acylethanolamines may actively induce tissue damage under stress conditions.

Conclusions:

  • Cannabinoids, particularly N-acylethanolamines, exhibit significant potential as anticancer agents.
  • Understanding the complex signaling pathways is crucial for therapeutic development.
  • Further research into the stress-induced mechanisms of N-acylethanolamines is warranted.

Related Concept Videos

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its effects by...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates these...